Gonadotropin preparation

HMG

HMG denotes a gonadotropin preparation. The supplier lists activity in IU; the FSH/LH composition and assay basis require supplier documentation.

SKU: G75
Quantity per vial

Availability: To be confirmed

10-vial kit

10 × 75 IU = 750 IU / box

$169.00 / boxCalculated equivalent: $16.90 per vial. Sold by package.

Catalog price in USD.

Requested: 10 vials · 750 IU

Products subtotal$169.00

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings

Human study · Study formulation · 50 women undergoing ovarian stimulation

Follicular response

The study compared a specified menotropin formulation with purified FSH; responses differed between groups.

Filicori et al., 2001 →

Literature findings; refer to the model and formulation studied.

Mechanism of action

HMG — gonadotropin preparation. The literature identity must be matched to the documented chemical form and composition of the supplied material.

The study compared a menotropin preparation with defined FSH and LH activities against highly purified FSH. LH activity was analyzed in folliculogenesis and controlled ovarian stimulation. Activity units in the studied preparation do not confirm the composition of another HMG material.

  • Gonadotropin signaling

Filicori et al., 2001

Studied findings 1
Human study · Study formulation

Follicular response

50 women undergoing ovarian stimulation

The study compared a specified menotropin formulation with purified FSH; responses differed between groups.

View context
Study design
Original-study abstract; experimental design described in linked source
Sample scope / arm
Not extracted; consult original study
Comparator
See original-study context
Experimental context (not instructions for use)
Abstract-level extraction; full methods and tables still require review.
Source section / table / abstract
Abstract

Evidence concerns the studied material and model, not the supplied BLOPEP batch.

Filicori et al., 2001

Sources and studies 1
  1. Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation.

    Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli De Fatis C, Pocognoli P, Cantelli B, Boschi S · 2001 · The Journal of clinical endocrinology and metabolism

    DOI: 10.1210/jcem.86.1.7108

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Biologic material
SKU
G75
Container or format
vial
Amount per unit
75 IU
Units per package
10
Nominal content per package
750 IU
Source commercial specification
75 IU

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.